Literature DB >> 18194672

Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation.

Gianna Ferretti1, Tiziana Bacchetti, Simona Masciangelo, Giosafatte Pallotta.   

Abstract

OBJECTIVES: Renal failure is associated with several metabolic disturbances and increasing evidences support a role of oxidative stress and impaired antioxidant defence in the pathologic mechanisms that may contribute to accelerated atherogenesis in these patients. Aim of the study was to further investigate the relationship between oxidative stress and chronic renal failure. DESIGN AND METHODS: We compared the paraoxonase (PON1) activity, the levels of lipid hydroperoxides and AGE adducts in plasma of hemodialysis patients before and after intravenous administration of vitamin C.
RESULTS: An increase in lipid hydroperoxides, AGE adducts and a decrease in the activity of PON1 were observed in patients with respect to controls. The comparison before and after supplementation with vitamin C showed an increase of PON1 activity and a decrease of AGE and lipid hydroperoxides levels.
CONCLUSIONS: The results provide further evidence that lipid peroxidation and impairment of antioxidant system in plasma of patients may play a role in renal disease and suggest that evaluation of PON1 activity could represents an useful approach to monitor antioxidant treatment and new dialysis therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18194672     DOI: 10.1016/j.clinbiochem.2007.12.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

Review 1.  Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease.

Authors:  Kazuhiko Kotani; Satoshi Kimura; Alejandro Gugliucci
Journal:  J Physiol Biochem       Date:  2011-04-12       Impact factor: 4.158

2.  Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma.

Authors:  Ugur Yilmaz Mumcu; Ibrahim Kocer; Orhan Ates; H Hakan Alp
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

3.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

4.  The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatment.

Authors:  Servin Yeşil Günal; Bilal Ustündağ; Ali İhsan Günal
Journal:  Indian J Clin Biochem       Date:  2013-03-26

5.  Paraoxonase 1 in chronic kidney failure.

Authors:  Alejandro Gugliucci; Kazuhiko Kotani; Satoshi Kimura
Journal:  J Lipids       Date:  2012-03-07

Review 6.  PON1 and Mediterranean Diet.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Nutrients       Date:  2015-05-27       Impact factor: 5.717

7.  Plasma protein-bound di-tyrosines as biomarkers of oxidative stress in end stage renal disease patients on maintenance haemodialysis.

Authors:  Graziano Colombo; Francesco Reggiani; David Cucchiari; Nicola M Portinaro; Daniela Giustarini; Ranieri Rossi; Maria Lisa Garavaglia; Nicola Saino; Aldo Milzani; Salvatore Badalamenti; Isabella Dalle-Donne
Journal:  BBA Clin       Date:  2017-01-05

Review 8.  The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases.

Authors:  José M Lou-Bonafonte; Clara Gabás-Rivera; María A Navarro; Jesús Osada
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

Review 9.  Two Faces of Vitamin C in Hemodialysis Patients: Relation to Oxidative Stress and Inflammation.

Authors:  Patrick Chaghouri; Nour Maalouf; Sophia Lorina Peters; Piotr Jan Nowak; Katarzyna Peczek; Anna Zasowska-Nowak; Michal Nowicki
Journal:  Nutrients       Date:  2021-02-27       Impact factor: 5.717

10.  Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.

Authors:  Parisa Younessi; Ali Yoonessi
Journal:  Iran J Med Sci       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.